International Stem Cell (ISCO) Accounts Payables (2016 - 2025)
Historic Accounts Payables for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $265000.0.
- International Stem Cell's Accounts Payables fell 1744.55% to $265000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $265000.0, marking a year-over-year decrease of 1744.55%. This contributed to the annual value of $186000.0 for FY2024, which is 4890.11% down from last year.
- According to the latest figures from Q3 2025, International Stem Cell's Accounts Payables is $265000.0, which was down 1744.55% from $397000.0 recorded in Q2 2025.
- International Stem Cell's 5-year Accounts Payables high stood at $635000.0 for Q1 2022, and its period low was $186000.0 during Q4 2024.
- Moreover, its 5-year median value for Accounts Payables was $377000.0 (2024), whereas its average is $401263.2.
- In the last 5 years, International Stem Cell's Accounts Payables soared by 5626.6% in 2021 and then tumbled by 4890.11% in 2024.
- International Stem Cell's Accounts Payables (Quarter) stood at $508000.0 in 2021, then plummeted by 36.61% to $322000.0 in 2022, then rose by 13.04% to $364000.0 in 2023, then crashed by 48.9% to $186000.0 in 2024, then surged by 42.47% to $265000.0 in 2025.
- Its last three reported values are $265000.0 in Q3 2025, $397000.0 for Q2 2025, and $457000.0 during Q1 2025.